REAX1 Options Volume

4 REAX1 option contracts changed hands in the latest session, at a put/call volume ratio of 0.00. This page tracks how actively REAX1 options trade — contracts and dollars — and flags individual contracts running far above their own 30-day average volume.

Data as of Oct 8, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

ATM IV (30d)
0.0%
Expected move
±0.0%
Put/call OI
0.09
Call-heavy
Max pain
$2

Chat with OptAI about REAX1


Options Volume & Premium Flow

Total options volume4
Call volume4
Put/call volume ratio0.00
Listed contracts34

REAX1 Unusual Options Activity

No REAX1 contract currently trades at 3× its 30-day average volume with at least 500 contracts — nothing clears OptiView's unusual-activity bar today.

With a put/call volume ratio of 0.00, today's trading is tilted toward calls.

Explore the payoff profile of option on REAX1 for free

Build multi-leg REAX1 strategies, visualize payoffs, and scan the full US options universe with OptiView.

REAX1 Options FAQ

How many REAX1 options traded today?

4 REAX1 option contracts traded as of Oct 8, 2026.

Is there unusual options activity in REAX1 today?

No REAX1 contract currently clears OptiView's unusual-activity bar as of Oct 8, 2026, which requires at least 3× the contract's 30-day average volume and 500 contracts traded.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.